Automated bioprocessing can significantly improve CAR T cell manufacturing by reducing errors and enhancing scalability. Explore how this approach supports consistent, high-quality cell therapy production.

Explore advanced magnetic bead-based methods for isolating T cells, enabling high efficiency, scalability, and viability in CAR T cell manufacturing while addressing challenges posed by diverse patient samples.

We outline the incorporation of magnetic bead separation technology into a cell processing platform designed specifically for cell therapy applications.

Learn more about modular, fit-for-purpose platforms designed specifically to meet the requirements of cell therapy manufacturing right now, and in the future.

Explore strategies for optimizing AAV gene therapy manufacturing. Discover solutions for scaling production, enhancing purification, and improving analytical methods to accelerate therapeutic development.

Learn how advanced technologies and methodologies are driving progress in gene therapy, enabling safer and more effective treatments for rare and complex diseases.

Delve into the cell therapy workflow and experience the patient as a focal point throughout their journey. Explore how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.

Whether you’re new to cell therapy manufacturing or expanding your existing knowledge base, this educational handbook provides the major considerations for successful cell therapy manufacturing.

In this eBook, a panel of key thought leaders share their perspectives on current obstacles and future developments in scale up and process development.